| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAZ | Common Stock | Sale | -$4.12M | -85.7K | -5.22% | $48.05 | 1.56M | Sep 3, 2024 | Direct | F1, F2 |
| transaction | LAZ | Common Stock | Sale | -$100K | -2.03K | -0.13% | $49.25 | 1.55M | Sep 3, 2024 | Direct | F1, F3 |
| transaction | LAZ | Common Stock | Sale | -$3.35M | -69.7K | -25.25% | $48.05 | 206K | Sep 3, 2024 | By Trust | F1, F4, F5 |
| transaction | LAZ | Common Stock | Sale | -$100K | -2.03K | -0.98% | $49.25 | 204K | Sep 3, 2024 | By Trust | F1, F3, F5 |
| transaction | LAZ | Common Stock | Sale | -$33.5K | -700 | -0.05% | $47.90 | 1.55M | Sep 4, 2024 | Direct | F1 |
| transaction | LAZ | Common Stock | Sale | -$1.39M | -28.8K | -1.86% | $48.30 | 1.52M | Sep 4, 2024 | Direct | F1, F6 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024. |
| F2 | The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on September 3, 2024 in trades with average execution prices ranging from $47.66 to $48.56, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report. |
| F3 | The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on September 3, 2024 in trades with average execution prices ranging from $49.08 to $49.54, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report. |
| F4 | The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on September 3, 2024 in trades with average execution prices ranging from $47.65 to $48.58, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report. |
| F5 | The shares are held in the Kenneth M. Jacobs 2005 GRAT, of which the Reporting Person is a co-trustee. |
| F6 | The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on September 4, 2024 in trades with average execution prices ranging from $48.06 to $48.98, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report. |